Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael Wakeman. (2021) A Literature Review of the Potential Impact of Medication on Vitamin D Status. Risk Management and Healthcare Policy 14, pages 3357-3381.
Read now
Read now
Articles from other publishers (31)
L. Veremme, A. Baudouin, A. Janoly-Dumenil & B. Charpiat. (2023) Thésaurus d’interventions pharmaceutiques associées aux prescriptions injustifiées d’inhibiteurs de la pompe à protons. Annales Pharmaceutiques Françaises 81:3, pages 552-567.
Crossref
Crossref
Salvatore Crisafulli, Elisabetta Poluzzi, Carlotta Lunghi, Vincenzo Di Francesco, Luca Pellizzari, Luca Pasina, Chiara Elli, Francesco Trotta, Agnese Cangini, Caterina Trevisan, Maria Beatrice Zazzara, Graziano Onder & Gianluca Trifirò. (2022) Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective. Frontiers in Drug Safety and Regulation 2.
Crossref
Crossref
Damien Cateau, Pierluigi Ballabeni & Anne Niquille. (2021) Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial. BMC Geriatrics 21:1.
Crossref
Crossref
Anne Spinewine, Perrine Evrard & Carmel Hughes. (2021) Interventions to optimize medication use in nursing homes: a narrative review. European Geriatric Medicine 12:3, pages 551-567.
Crossref
Crossref
Wei Liu, John P. Haran, Arlene S. Ash, Jeroan J. Allison, Shangyuan Ye, Jenifer Tjia, Vanni Bucci & Bo Zhang. (2020) High-dimensional Causal Mediation Analysis with a Large Number of Mediators Clumping at Zero to Assess the Contribution of the Microbiome to the Risk of Bacterial Pathogen Colonization in Older Adults. Current Bioinformatics 15:7, pages 671-696.
Crossref
Crossref
Erik Puchon, Maria Goboova, Ivan Vano, Tomas Fazekas, Zuzana Javorova-Rihova & Magdalena Kuzelova. (2020) Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults. European Geriatric Medicine 11:6, pages 1051-1061.
Crossref
Crossref
Luca Pasina, A. Novella, L. Cortesi, A. Nobili, M. Tettamanti & A. Ianes. (2020) Drug prescriptions in nursing home residents: an Italian multicenter observational study. European Journal of Clinical Pharmacology 76:7, pages 1011-1019.
Crossref
Crossref
Rianne M. Douwes, António W. Gomes-Neto, Michele F. Eisenga, Elisabet Van Loon, Joëlle C. Schutten, Rijk O. B. Gans, Maarten Naesens, Else van den Berg, Ben Sprangers, Stefan P. Berger, Gerjan Navis, Hans Blokzijl, Björn Meijers, Stephan J. L. Bakker & Dirk Kuypers. (2020) The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study. PLOS Medicine 17:6, pages e1003140.
Crossref
Crossref
Helena Jenzer & Leila Sadeghi-Reeves. (2020) Nutrigenomics-Associated Impacts of Nutrients on Genes and Enzymes With Special Consideration of Aromatase. Frontiers in Nutrition 7.
Crossref
Crossref
Luca Pasina, Alessio Novella, Chiara Elli, Alessandro Nobili & Aladar Ianes. (2020) Overuse of proton pump inhibitors in nursing homes: An Italian multicenter observational study. Pharmacoepidemiology and Drug Safety 29:4, pages 461-466.
Crossref
Crossref
Rónán O’Caoimh, Nicola Cornally, Ciara McGlade, Yang Gao, Eileen O’Herlihy, Anton Svendrovski, Roger Clarnette, Amanda Hanora Lavan, Paul Gallagher & D. William Molloy. (2019) Reducing inappropriate prescribing for older adults with advanced frailty: A review based on a survey of practice in four countries. Maturitas 126, pages 1-10.
Crossref
Crossref
Laura Targownik. (2018) Discontinuing Long-Term PPI Therapy: Why, With Whom, and How?. American Journal of Gastroenterology 113:4, pages 519-528.
Crossref
Crossref
Surapon Nochaiwong, Chidchanok Ruengorn, Ratanaporn Awiphan, Kiatkriangkrai Koyratkoson, Chayutthaphong Chaisai, Kajohnsak Noppakun, Wilaiwan Chongruksut & Kednapa Thavorn. (2018) The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis. Nephrology Dialysis Transplantation 33:2, pages 331-342.
Crossref
Crossref
Mona Boudabous, Héla Gdoura, Leila Mnif, Lassad Chtourou, Amal Grati, Ali Amouri & Nabil Tahri. 2017. Esophageal Abnormalities. Esophageal Abnormalities.
Heidi Juntunen, Heidi Taipale, Antti Tanskanen, Anna-Maija Tolppanen, Jari Tiihonen, Sirpa Hartikainen & Miia Tiihonen. (2017) Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer’s disease. European Journal of Clinical Pharmacology 73:9, pages 1149-1158.
Crossref
Crossref
Leon Fisher & Alexander Fisher. (2017) Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clinical Drug Investigation 37:7, pages 587-624.
Crossref
Crossref
Laura E Targownik, Andrew L Goertzen, Yunhua Luo & William D Leslie. (2017) Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure. American Journal of Gastroenterology 112:1, pages 95-101.
Crossref
Crossref
Mohammad Rababa, Amal Ali Al-Ghassani, Christine R. Kovach & Elaine M. Dyer. (2016) Proton Pump Inhibitors and the Prescribing Cascade. Journal of Gerontological Nursing 42:4, pages 23-31.
Crossref
Crossref
Maartje H. de Groot, Jos P. C. M. van Campen, Nienke M. Kosse, Oscar J. de Vries, Jos H. Beijnen & Claudine J. C. Lamoth. (2016) The Association of Medication-Use and Frailty-Related Factors with Gait Performance in Older Patients. PLOS ONE 11:2, pages e0149888.
Crossref
Crossref
Inês Tomada & José Paulo Andrade. 2015. Anti-ageing nutrients. Anti-ageing nutrients
333
390
.
Grigorios I. Leontiadis & Paul Moayyedi. (2014) Proton Pump Inhibitors and Risk of Bone Fractures. Current Treatment Options in Gastroenterology 12:4, pages 414-423.
Crossref
Crossref
Jian Ding, Debra A. Heller, Frank M. Ahern & Theresa V. Brown. (2014) The Relationship Between Proton Pump Inhibitor Adherence and Fracture Risk in the Elderly. Calcified Tissue International 94:6, pages 597-607.
Crossref
Crossref
Gwen M. C. Masclee, Miriam C. J. M. Sturkenboom & Ernst J. Kuipers. (2014) A Benefit–Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly. Drugs & Aging 31:4, pages 263-282.
Crossref
Crossref
Marjan Askari, Saied Eslami, Alice C. Scheffer, Stephanie Medlock, Sophia E. de Rooij, Nathalie van der Velde & Ameen Abu-Hanna. (2013) Different Risk-Increasing Drugs in Recurrent versus Single Fallers: Are Recurrent Fallers a Distinct Population?. Drugs & Aging 30:10, pages 845-851.
Crossref
Crossref
Deborah Patterson Burdsall, Hanzel C. Flores, Jill Krueger, Sandra Garretson, Martin J. Gorbien, Amy Iacch, Vicky Dobbs & Theodore Homa. (2013) Use of Proton Pump Inhibitors With Lack of Diagnostic Indications in 22 Midwestern US Skilled Nursing Facilities. Journal of the American Medical Directors Association 14:6, pages 429-432.
Crossref
Crossref
Philipe de Souto Barreto, Maryse Lapeyre-Mestre, Céline Mathieu, Christine Piau, Catherine Bouget, Françoise Cayla, Bruno Vellas & Yves Rolland. (2013) Prevalence and Associations of the Use of Proton-Pump Inhibitors in Nursing Homes: A Cross-Sectional Study. Journal of the American Medical Directors Association 14:4, pages 265-269.
Crossref
Crossref
Laura E Targownik, William D Leslie, Shawn K Davison, David Goltzman, Sophie A Jamal, Nancy Kreiger, Robert G Josse, Stephanie M Kaiser, Christopher S Kovacs, Jerilynn C Prior & Wei Zhou. (2012) The Relationship Between Proton Pump Inhibitor Use and Longitudinal Change in Bone Mineral Density: A Population-Based From the Canadian Multicentre Osteoporosis Study (CaMos). American Journal of Gastroenterology 107:9, pages 1361-1369.
Crossref
Crossref
Yuen Ting Lau & Nasiya N. Ahmed. (2012) Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:1, pages 67-79.
Crossref
Crossref
Emily P. Peron, Shelly L. Gray & Joseph T. Hanlon. (2011) Medication Use and Functional Status Decline in Older Adults: A Narrative Review. The American Journal of Geriatric Pharmacotherapy 9:6, pages 378-391.
Crossref
Crossref
Xiaofei Ye, Hong Liu, Cheng Wu, Yingyi Qin, Jiajie Zang, Qingbin Gao, Xinji Zhang & Jia He. (2011) Proton pump inhibitors therapy and risk of hip fracture. European Journal of Gastroenterology & Hepatology 23:9, pages 794-800.
Crossref
Crossref
Emily P. Peron, Zachary A. Marcum, Richard Boyce, Joseph T. Hanlon & Steven M. Handler. (2011) Year in Review: Medication Mishaps in the Elderly. The American Journal of Geriatric Pharmacotherapy 9:1, pages 1-10.
Crossref
Crossref